Skip to main content
Livermore
Livermore
ZHEN

Metacrine, Inc.

MTCRDelisted Mar 3, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001634379

Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Metacrine, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

MTCR is no longer listed, and 13F filings after Q4 2022 list far fewer holders. See Q4 2022

Institutional holders
0
−5 vs. Q1 2023
Shares held
0
−9.29M (−100.0%) vs. Q1 2023
Total value
$0
−$5.30M (−100.0%) vs. Q1 2023
New holders
0
0 more added
Sold out
5
0 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MTCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 0 institutions
Q1 2021: 47 institutionsQ2 2021: 42 institutionsQ3 2021: 35 institutionsQ4 2021: 31 institutionsQ1 2022: 31 institutionsQ2 2022: 25 institutionsQ3 2022: 27 institutionsQ4 2022: 29 institutionsQ1 2023: 5 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $0
Q1 2021: $82.1MQ2 2021: $47.4MQ3 2021: $37.9MQ4 2021: $2.23MQ1 2022: $3.83MQ2 2022: $3.06MQ3 2022: $3.93MQ4 2022: $7.29MQ1 2023: $5.30MQ2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding MTCR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20235$5.30M
Q4 202229$7.29M
Q3 202227$3.93M
Q2 202225$3.06M
Q1 202231$3.83M
Q4 202131$2.23M
Q3 202135$37.9M
Q2 202142$47.4M
Q1 202147$82.1M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Metacrine, Inc.; share changes are against Q1 2023.

Institutions holding MTCR in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
BML Capital Management, LLC0$00.00%−6,167,458−100.0%Sold out
JBF Capital, Inc.0$00.00%−1,945,270−100.0%Sold out
Artal Group S.A.0$00.00%−924,898−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−239,100−100.0%Sold out
Wedbush Securities Inc0$00.00%−12,700−100.0%Sold out